J. Flores-hernandez et al., D-1 dopamine receptor activation reduces GABA(A) receptor currents in neostriatal neurons through a PKA/DARPP-32/PP1 signaling cascade, J NEUROPHYS, 83(5), 2000, pp. 2996-3004
Dopamine is a critical determinant of neostriatal function, but its impact
on intrastriatal GABAergic signaling is poorly understood The role of D-1 d
opamine receptors in the regulation of postsynaptic GABA(A) receptors was c
haracterized using whole cell voltage-clamp recordings in acutely isolated,
rat neostriatal medium spiny neurons. Exogenous application of GABA evoked
a rapidly desensitizing current that was blocked by bicuculline. Applicati
on of the D-1 dopamine receptor agonist SKF 81297 reduced GABA-evoked curre
nts in most medium spiny neurons. The D-1 dopamine receptor antagonist SCH
23390 blocked the effect of SKF 81297. Membrane-permeant cAMP analogues mim
icked the effect of D-1 dopamine receptor stimulation, whereas an inhibitor
of protein kinase A (PKA; Rp-8-chloroadenosine 3',5' cyclic monophosphothi
oate) attenuated the response to D-1 dopamine receptor stimulation or cAMP
analogues. Inhibitors of protein phosphatase 1/2A potentiated the modulatio
n by cAMP analogues. Single-cell RT-PCR profiling revealed consistent expre
ssion of mRNA for the beta 1 subunit of the GABA(A) receptor-a known substr
ate of PKA-in medium spiny neurons. Immunoprecipitation assays of radiolabe
led proteins revealed that D-1 dopamine receptor stimulation increased phos
phorylation of GABA(A) receptor beta 1/beta 3 subunits. The D-1 dopamine re
ceptor-induced phosphorylation of beta 1/beta 3 subunits was attenuated sig
nificantly in neostriata from DARPP-32 mutants. Voltage-clamp recordings co
rroborated these results, revealing that the efficacy of the D-1 dopamine r
eceptor modulation of GABA(A) currents was reduced in DARPP-32-deficient me
dium spiny neurons. These results argue that D-1 dopamine receptor stimulat
ion in neostriatal medium spiny neurons reduces postsynaptic GABA(A) recept
or currents by activating a PKA/DARPP-32/protein phosphatase 1 signaling ca
scade targeting GABA(A) receptor beta 1 subunits.